Daiichi Sankyo promotes Ken Keller to lead new commercialization unit

Daiichi Sankyo is promoting Ken Keller to lead a new globally integrated commercialization unit, putting the executive in charge of a key pillar of its push to become a top-five oncology company by 2035.